Vaxneuvance, Injektionssuspension - Swissmedic Key 68752001 Registration Holder MSD Merck Sharp & Dohme AG Name Vaxneuvance, Injektionssuspension Date of registration 14.02.2023 Introduction of Sequence 14.02.2023 ATC-Classification Pneumococcus, Purified Polysaccharides Antigen Conjugated (J07AL02) Revision date WHO WHO-DDD Valid until 13.02.2028 Index Therapeuticus (BSV) 08.08. Show package size Index Therapeuticus (Swissmedic) 08.08. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 58.28 Limitation Yes Limitation text
Deductible 10 % Consumer price 79.80 Feedback FB GTIN 7680687520010 Medication Code Impfstoffe Pharmacode Disponibility
Composition polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg et polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg corresp. polysaccharida 32 µg et proteinum corynebacteriae diphtheriae CRM 197 ca. 30 µg, adjuvans: aluminium 0.125 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.77 mg, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml. Packungsbestandteile Galenic Form Injection suspension Excipiens Active Agent Dose 2µg / 0.5ml 2µg / 0.5ml 2µg / 0.5ml 2µg / 0.5ml 2µg / 0.5ml 2µg / 0.5ml correspond Polysaccharida 32µg / 0.5ml 2µg / 0.5ml 4µg / 0.5ml 2µg / 0.5ml 2µg / 0.5ml
Inactive agents Dose additional_information Alumine 0.125mg / 0.5ml adjuvans 2µg / 0.5ml Histidine Sodium Chloride 14 30µg / 0.5ml
Source Data was imported : 03.03.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
